Posted on April 21, 2021
The uneven availability of COVID-19 vaccines has become an increasingly urgent and vexatious issue. But managing the problem of what's been labelled "vaccine nationalism" is proving a hard nut to crack. Shortages of medicines and vulnerable supply chains for critical medicines are issues for nearly all developing countries. In Africa, in particular, there's limited manufacturing capacity. Over 20 countries don't have any capacity at all. And many regions continue to import at least 95% of their pharmaceutical requirements. (SABC News, 20 April 2021)
Copyright © University of Pretoria 2024. All rights reserved.
Virtual Campus
Get Social With Us
Download the UP Mobile App